200 related articles for article (PubMed ID: 22142478)
1. An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease.
Bando M; Miyazawa T; Shinohara H; Owada T; Terakado M; Sugiyama Y
Respirology; 2012 Apr; 17(3):493-8. PubMed ID: 22142478
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
[TBL] [Abstract][Full Text] [Related]
4. Poor sensitivity of symptoms in early detection of COPD.
Akamatsu K; Yamagata T; Kida Y; Tanaka H; Ueda H; Ichinose M
COPD; 2008 Oct; 5(5):269-73. PubMed ID: 18972274
[TBL] [Abstract][Full Text] [Related]
5. COPD in Japan: the Nippon COPD Epidemiology study.
Fukuchi Y; Nishimura M; Ichinose M; Adachi M; Nagai A; Kuriyama T; Takahashi K; Nishimura K; Ishioka S; Aizawa H; Zaher C
Respirology; 2004 Nov; 9(4):458-65. PubMed ID: 15612956
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
[TBL] [Abstract][Full Text] [Related]
7. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
[TBL] [Abstract][Full Text] [Related]
8. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological actions of statins: potential utility in COPD.
Young RP; Hopkins R; Eaton TE
Eur Respir Rev; 2009 Dec; 18(114):222-32. PubMed ID: 20956147
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan.
Onishi K; Yoshimoto D; Hagan GW; Jones PW
Int J Chron Obstruct Pulmon Dis; 2014; 9():563-8. PubMed ID: 24920894
[TBL] [Abstract][Full Text] [Related]
11. Associations of lifelong cigarette consumption and hypertension with airflow limitation in primary care clinic outpatients in Japan.
Utsugi H; Nakamura H; Suzuki T; Maeno T; Nagata M; Kanazawa M
Respir Investig; 2016 Jan; 54(1):35-43. PubMed ID: 26718143
[TBL] [Abstract][Full Text] [Related]
12. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
[TBL] [Abstract][Full Text] [Related]
13. [The rate of airflow limitation among the elderly undergoing spirometry in a university hospital].
Tojo N; Umino T; Miyasaka N
Rinsho Byori; 2004 Aug; 52(8):649-54. PubMed ID: 15478620
[TBL] [Abstract][Full Text] [Related]
14. Undiagnosed airflow limitation in patients at cardiovascular risk.
Bérard E; Bongard V; Roche N; Perez T; Brouquières D; Taraszkiewicz D; Fievez S; Denis F; Escamilla R; Ferrières J
Arch Cardiovasc Dis; 2011 Dec; 104(12):619-26. PubMed ID: 22152514
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive lung disease-related health care utilisation in Korean adults with obstructive lung disease.
Jung JY; Kang YA; Park MS; Oh YM; Park EC; Kim HR; Lee SD; Kim SK; Chang J; Kim YS
Int J Tuberc Lung Dis; 2011 Jun; 15(6):824-9. PubMed ID: 21575306
[TBL] [Abstract][Full Text] [Related]
16. Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001.
Melbye H; Halvorsen DS; Hartz I; Medbø A; Brox J; Eggen AE; Njølstad I
Respir Med; 2007 Dec; 101(12):2541-9. PubMed ID: 17825547
[TBL] [Abstract][Full Text] [Related]
17. The impact of smoking on airflow limitation in subjects with history of asthma and inactive tuberculosis.
Kim HJ; Baek S; Kim HJ; Lee JS; Oh YM; Lee SD; Lee SW
PLoS One; 2015; 10(4):e0125020. PubMed ID: 25915938
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan.
Omori H; Kaise T; Suzuki T; Hagan G
Int J Chron Obstruct Pulmon Dis; 2016; 11():873-80. PubMed ID: 27217740
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
Stav D; Raz M
Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
